305 related articles for article (PubMed ID: 10665739)
21. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
22. Novel enzyme immunoassay system for simultaneous detection of six subclasses of antiphospholipid antibodies for differential diagnosis of antiphospholipid syndrome.
Nojima J; Motoki Y; Hara K; Sakata T; Ichihara K
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):316-322. PubMed ID: 27676644
[TBL] [Abstract][Full Text] [Related]
23. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
24. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
[TBL] [Abstract][Full Text] [Related]
25. IgM, but not IgA rheumatoid factor interferes with anti-cardiolipin and antiβ2 glycoprotein I measurements: a quantitative analysis.
Lakos G; Teodorescu M
Lupus; 2011 May; 20(6):614-9. PubMed ID: 21436214
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
[TBL] [Abstract][Full Text] [Related]
27. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
[TBL] [Abstract][Full Text] [Related]
28. Anti-BB'-Sm antibodies, anticardiolipin antibodies, and thrombosis in systemic lupus erythematosus.
López-Longo FJ; Monteagudo I; González CM; Moreno AC; Rodríguez Mahou M; Grau R; Carreño L
J Rheumatol; 1998 Sep; 25(9):1743-9. PubMed ID: 9733455
[TBL] [Abstract][Full Text] [Related]
29. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
Rodriguez VE; Gonzalez-Pares EN; Rivera C
P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
[TBL] [Abstract][Full Text] [Related]
30. [Value of the search for anticardiolipin antibodies during the course of systemic lupus erythematosus].
Gorgi Y; Ksouri H; Guermazii S; Ayed K; Dallagi K
Ann Med Interne (Paris); 1996; 147(8):531-5. PubMed ID: 9137678
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Samarkos M; Davies KA; Gordon C; Loizou S
Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839
[TBL] [Abstract][Full Text] [Related]
32. Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations, and impact on survival.
Gulko PS; Reveille JD; Koopman WJ; Burgard SL; Bartolucci AA; Alarcón GS
J Rheumatol; 1993 Oct; 20(10):1684-93. PubMed ID: 8295179
[TBL] [Abstract][Full Text] [Related]
33. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
[TBL] [Abstract][Full Text] [Related]
34. Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus.
Yoshio T; Masuyama J; Ikeda M; Tamai K; Hachiya T; Emori T; Mimori A; Takeda A; Minota S; Kano S
J Rheumatol; 1995 Sep; 22(9):1681-7. PubMed ID: 8523345
[TBL] [Abstract][Full Text] [Related]
35. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M
Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
Delgado Alves J; Ames PR; Donohue S; Stanyer L; Nourooz-Zadeh J; Ravirajan C; Isenberg DA
Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
[TBL] [Abstract][Full Text] [Related]
37. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
38. Anti-cardiolipin and anti-beta 2-glycoprotein I antibodies in celiac disease.
Mankaï A; Achour A; Thabet Y; Manoubia W; Sakly W; Ghedira I
Pathol Biol (Paris); 2012 Oct; 60(5):291-5. PubMed ID: 21839587
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of anti-cardiolipin antibody in patients with systemic lupus erythematosus (SLE)].
Aoki K; Takeuchi T; Itoh I; Takano Y; Itoh T; Hosono O; Koide J; Abe T
Ryumachi; 1994 Dec; 34(6):961-6. PubMed ID: 7863386
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of three commercial ELISA kits for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
Decavele AS; Schouwers S; Devreese KM
Int J Lab Hematol; 2011 Feb; 33(1):97-108. PubMed ID: 20813022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
